sitagliptin vs semaglutide A trial emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on cardiovascular outcomes in people at elevated cardiovascular risk with obesity and diabetes. Link A Pharmacological and Clinical Overview

Hanai T, Shiraki M, Ohnishi S, et al

They are CTR plus a RAMP , producing AMY receptor subtypes such as AMY1R, AMY2R, and AMY3R

The estimated cost of Wegovy and similar drugs for insurers, net of bulk discounts provided by manufacturers (Denmark-based Novo Nordisk for Wegovy and Ozempic and Indianapolis-based Eli Lilly for Mounjaro and Zepbound) runs from about $8,600 to $9,100 a year

2b) in male db / db mice following a single intraperitoneal (i.p.) injection

Semaglutide vs tirzepatide at 50 units Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GIP/GLP-1 agonist that also comes in compounded multi-dose vials